Tech Company Financing Transactions
Cytovance Biologics Funding Round
Cytovance Biologics secured a $20 million funding round on 10/28/2014. Investors included Monroe Capital.
Transaction Overview
Company Name
Announced On
10/28/2014
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to continue to grow operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
840 Research Pkwy. 200
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
biopharmaceutical contract manufacturing of therapeutic proteins and antibodies
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yan Wang
Vice President
Naomi Seresinhe
VP - Human Resources
Joyce Johnson
VP - Manufacturing
Michael O'Mara
VP - R & D
Jesse McCool
Browse more venture capital transactions:
Prev: 10/28/2014: Compass venture capital transaction
Next: 10/28/2014: QualiSystems venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs